"anyone care to explain if there is anyone other cartilage enhancing medicine out there ?"
Not going to be a popular question during this positive news. Do your research and the main competition comes from stem cells, autologous treatments are already available and induced pluripotent (off-the-shelf), leading the approaches in which both ironically originate from two Australian companies. Autologous are in market but practically no one knows of them and off the shelf still at stage 3 trial stage not that different to PAR in agenda. Competition not really a risk at this very early point.
Its a massive market anyway that will accommodate $billions in all three approaches without even touching 5% of sufferers:
"The pooled global prevalence of knee OA was 16⋅0% (95% CI, 14⋅3%-17⋅8%) in individuals aged 15 and over and was 22⋅9% (95% CI, 19⋅8%-26⋅1%) in individuals aged 40 and over."
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704420/
Its a ways to go, but the size of PAR's total addressable market is shudderingly huge.....this stock has been stupidly oversold in the great 'capital cost' sell off of non-FCF companies despite its massive potential forward earnings - even with a healthy risk probability applied.
- Forums
- ASX - By Stock
- Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
"anyone care to explain if there is anyone other cartilage...
-
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
0.015(6.52%) |
Mkt cap ! $85.7M |
Open | High | Low | Value | Volume |
23.0¢ | 24.5¢ | 23.0¢ | $116.0K | 491.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 33682 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.235 |
2 | 44021 | 0.230 |
1 | 100000 | 0.225 |
5 | 234973 | 0.220 |
4 | 96293 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 33682 | 3 |
0.250 | 59284 | 5 |
0.255 | 21666 | 2 |
0.260 | 41294 | 6 |
0.265 | 37500 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online